Behnood Bikdeli on Comparative Effectiveness Research Examples in Thrombosis
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared an insightful post on X:
“Comparative effectiveness studies can use double-blind RCT, pragmatic RCT, or observational designs with the Target Trial framework.
We break down internal, construct and external validity across designs, with examples in thrombosis.”
Read the full article here.
Title: Comparative Effectiveness Research Using Randomized Trials and Observational Studies: Validity and Feasibility Considerations
Authors: Behnood Bikdeli, Joseph S. Ross, Syed Bukhari, Molly M. Jeffery, Gregory Y.H. Lip, Seng Chan You, David J. Cohen, James L. Januzzi Jr, Joshua D. Wallach
Stay informed on the latest scientific advances in the field of thrombosis with Hemostasis Today.
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities